Barclays

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
9,146
Total Value
175908309
Accession Number
0000312069-25-000408
Form Type
13F-HR
Manager Name
Barclays
Data Enrichment
89% identified
8,179 identified967 unidentified

Holdings

9,146 positions • $175.9M total value
Manager:
Search and click to pin securities to the top
Page 226 of 226
Alaunos Therapeutics, Inc.
Shares:171
Value:$0
% of Portfolio:0.0% ($0/$175.9M)
66979P300
Shares:7
Value:$0
% of Portfolio:0.0% ($0/$175.9M)
DYADIC INTERNATIONAL INC
Shares:72
Value:$0
% of Portfolio:0.0% ($0/$175.9M)
696389402
Shares:6
Value:$0
% of Portfolio:0.0% ($0/$175.9M)
PATRIOT NATIONAL BANCORP INC
Shares:307
Value:$0
% of Portfolio:0.0% ($0/$175.9M)
TELA Bio, Inc.
Shares:4
Value:$0
% of Portfolio:0.0% ($0/$175.9M)
71880W501
Shares:5
Value:$0
% of Portfolio:0.0% ($0/$175.9M)
78464A474
Shares:1
Value:$0
% of Portfolio:0.0% ($0/$175.9M)
Dominari Holdings Inc.
Shares:31
Value:$0
% of Portfolio:0.0% ($0/$175.9M)
REVIVA PHARMACEUTICALS HOLDINGS, INC.
Shares:6
Value:$0
% of Portfolio:0.0% ($0/$175.9M)
71902K303
Shares:102
Value:$0
% of Portfolio:0.0% ($0/$175.9M)
RenovoRx, Inc.
Shares:43
Value:$0
% of Portfolio:0.0% ($0/$175.9M)